Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Jan;83(1):20-3.
doi: 10.1111/j.1349-7006.1992.tb02346.x.

Use of a local immunotherapy as an adjunctive tool for the generation of human monoclonal antibodies from regional lymph nodes of colonic cancer patients

T Yagyu  1 , T Monden, Y Tamaki, H Morimoto, T Takeda, T Kobayashi, T Shimano, H Murakami, T Mori
Affiliations

Use of a local immunotherapy as an adjunctive tool for the generation of human monoclonal antibodies from regional lymph nodes of colonic cancer patients

T Yagyu et al. Jpn J Cancer Res. 1992 Jan.

Abstract

Human hybridomas were generated through the fusion of the human B-lymphoblastoid cell line HO-323 with the regional lymph node lymphocytes of colonic cancer patients who had received a local immunotherapy. A total of 353 hybridomas were obtained from 4 patients and 116 of these were found to secrete greater than or equal to 100 ng/ml human immunoglobulin. The efficiency was remarkably high as compared with that from patients without the local immunotherapy. Further immunohistological examination showed that 5 hybridomas secreted IgM which selectively reacted with colonic cancers. The results indicate that local immunotherapy could be an adjunctive tool for the generation of highly potent human hybridomas through augmenting the host's immunity.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. ) Irie , R. F. , Matsuki , T. and Morton , D. L.Human monoclonal antibody to genglioside GM2 for melanoma treatment . Lancet , i , 786 – 787 ( 1989. ). - PubMed
    1. ) Borrebaeck , A. K. C.Strategy for the production of human monoclonal antibodies using in vitro activated B cells . J. Immunol. Methods. 123 , 157 – 165 ( 1989. ). - PubMed
    1. ) Koda , K. , Glassy , M. C. and Chang , H. R.Generation of human monoclonal antibodies against colon cancer . Arch. Surg. , 125 , 1591 – 1597 ( 1990. ). - PubMed
    1. ) Skaletsky , E. , Oh , E. , Rulot , C. , Baird , S. M. , Burnett , K. G. , Masuho , Y. , Astarita , R. W. , Haghighi , P. , Wolf , P. , Collins , H. , Starr , R. , Carlo , D. J. , Royston , I. and Sobol , R. E.A human monoclonal antibody to cytokeratin intermediate filament antigens derived from a tumor draining lymph node . Hybridoma. 7 , 367 – 376 ( 1988. ). - PubMed
    1. ) Vollmers , H. P. , O'Connor , R. , Müller , J. , Kirchner , T. and Müller‐Hermelink , H. K.SC‐1, a functional human monoclonal antibody against autologous stomach carcinoma cells . Cancer Res. , 49 , 2471 – 2476 ( 1989. ). - PubMed

MeSH terms

LinkOut - more resources